Managed Healthcare Executive
WEBStudy eases some of the concern about Crohn's disease and ulcerative colitis creating undue infection risk. Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.
Beyond the Big Three PBMs - Managed Healthcare Executive
WEBDec 19, 2022 · But beyond the big three PBMs is a swarm of some 60 smaller, up-and-coming PBMs. Even if they are operating in a small slice of the pie relative to the towering dominance of the big three, the PBM pie is growing rapidly. The global PBM market is projected to increase from $495 billion in 2022 to $740 billion by 2029 (a 50% jump), according to a ...
The Impact of Medicare Advantage Employer Group Waiver Plans
WEBMay 10, 2024 · Flexibility: Employer Group Waiver Plans can adapt to meet retiree needs and respond to emerging healthcare trends, ensuring that beneficiaries receive tailored and relevant care. Health Equity and Social Risk Factors: MA plans play a crucial role in advancing equity and reducing health disparities within Medicare, ensuring that all ...
Specialty Pharmacist Interventions Result in More Than $150,000 …
WEBApr 4, 2024 · A total of 39 interventions among 38 patients resulted in 50 cost-avoidance opportunities. Of these, 13 were associated with direct costs and 37 involved indirect costs. The total estimated avoided costs for six months ranged from $123,733 to $156,265. Of these amounts, $138,410 was due to direct costs, and $1,890 was associated with indirect ...
MHE Question of the Week: Health Insurance Coverage of GLP-1s …
WEBMar 6, 2024 · The glucagon-like peptide 1 (GLP-1) drugs is a class that includes now-famous Ozempic (semaglutide) and Mounjaro (tirzepatide), which were approved by the FDA as diabetes treatments but have been used off-label for weight loss.
Michael A. Carson Takes on Role of President, CEO of Centene's …
WEBJan 29, 2024 · Michael A. Carson has recently been appointed as president and CEO of Centene Corporation’s Medicare business, Wellcare. Carson, who succeeds Richard Fisher, will now be responsible for Medicare business performance, strategy and the growth of Wellcare. Before serving nearly three decades in …
Formulary Digital Edition, June 2010
WEBJun 1, 2010 · Formulary Digital Edition, June 2010. June 1, 2010. News. Article. Pulmonary arterial hypertension: Bridging the gap between efficacy, quality of life, and cost-effectiveness; Lorcaserin: A novel, selective 5-HT2C-receptor agonist for the treatment of obesity; Vaccine agents in late-stage development.
Evernorth is “Foundational” to Cigna’s Business
WEBFeb 2, 2024 · The Cigna Group’s 2023 revenue grew to $195.3 billion, up 8% compared with 2022’s revenue of $180.6 billion. In the fourth quarter of 2023, Cigna’s revenue was up 12%, which company officials said in an earnings call reflects strong growth at both Evernorth Health Services and Cigna Healthcare.
Future Perspectives on Atopic Dermatitis Treatment
WEBJun 3, 2024 · Future Perspectives on Atopic Dermatitis Treatment. June 3, 2024. By Lawrence Eichenfield, MD. Opinion. Video. Focusing on the future treatment landscape of atopic dermatitis, Dr Eichenfield discusses current unmet needs and highlights standout studies and presentations from the 2024 AAD Annual Meeting.
Depression - managedhealthcareexecutive.com
WEBSeptember 17th 2024. The FDA rejected an application to approve MDMA, also known as ecstasy, as a treatment for PTSD. Next up among the psychedelics vying for FDA approval: psilocybin for treatment resistant depression.